The latest research indicates that “Sinovac” 3 needles or stimulants. It is more effective in preventing COVID-19 if you stay several months away from the 2nd dose.
The latest research indicates that “Sinovac” 3 needles or stimulants. It is more effective in preventing COVID-19 if you stay several months away from the 2nd dose.
Bloomberg News reported the findings published in the Medical Journal. The Lancet indicates that longer intervals between injectionsVaccines against COVID-19 of the companySinovacThe second needle andNeedle 3 orstimulation needlethat will increase the efficiency of virus protectionCovid-19 more than shorter intervals
Researchers from the companySinovac Biotech, UniversityFutanin Shanghai andCenters for Disease Control and PreventionMany regional levels say that people who have been vaccinatedNeedle 3 (booster) after receiving the 2nd needlefor 8 monthsImmunity levels were more than doubled compared to those who received the booster dose within two months of receiving the second dose.
While the research found that after vaccinationCoronavac (CoronaVac) completed 2 doses for that 6 months efficiencyof vaccines to preventCovid-19 has decreased dramatically The third dose vaccination after 8 months of the second dose vaccination resulted inimmunitygreatly increased
The research comes at a time when countries around the world have accelerated injections.booster vaccineto the people because a virus was detectedOmikron which is a virusCovid-19 New strains that are more contagious
In some countries such as South Koreahas shortened the distance between the 2nd and 3rd injections to only 3 monthsvaccine dose 3 It may not be the best approach forinactivated vaccinethingsSinovac
Mr Ugur Sahin, CEO of the companybiotech (BioNTech), which produces vaccines mRNA It supports strategies to shorten the distance of double-drug vaccination.booster needle
althoughsinovac vaccineIt remains highly effective in preventing serious illness and death from disease.Covid-19 but backThey are less capable of preventing infection and the development of symptomatic disease caused by primitive and delta strains. compared to vaccines mRNA
Currently, the vaccine is usedSinovacThe most widely spread around the world with delivery todeveloping countryMostly about 2.3 billion doses andSinovacResearch on the effectiveness ofvaccinein protection against virus strainsOmikron
Dr. Wang Huaqing, chief immunization expert at the China Centers for Disease Control and Prevention. said at a briefing last November that people getbooster vaccinealready about 38 million people across China
partHong Konghas started vaccinationstimulation needleOn November 11, the past forhigh risk groupwho received the vaccineSinovac The research results published on Dec. 7 also indicate that People aged 60 and over are immune to higher levels of the 3rd dose vaccination. compared to the people aged 18-59 years.
.
